+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Psychedelics in Psychiatry. International Review of Neurobiology Volume 181

  • Book

  • June 2025
  • Region: Global
  • Elsevier Science and Technology
  • ID: 6035961
Psychedelics in Psychiatry, Volume 181, the latest release in the International Review of Neurobiology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Chapters in this new volume include History of psychedelic drug science and molecular pharmacology, Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents, Anti-inflammatory activity, Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents, Clinical pharmacology, Human neuroimaging fMRI, and more.

Other chapters in this new release include Effects of psychedelics on human oscillatory brain activity, Molecular neuroimaging of psychedelic drug effects, Neurobiology of sub-psychedelic doses, Depression and related disorders, Addictions, Trauma disorders, Neurological disorders, and Challenges to the developing field of psychedelic medicine - political and ethical considerations and commercialization of therapy.

Table of Contents

Section 1 1. History of psychedelic drug science and molecular pharmacology 2. Pharmacological mechanisms and neuroplastic potential of non-psychedelic agents 3. Anti-inflammatory activity 4. Translational approaches for investigating the effects of psychedelics on cognitive and affective behaviors in rodents 5. Clinical pharmacology 6. Human neuroimaging fMRI 7. Effects of psychedelics on human oscillatory brain activity 8. Molecular neuroimaging of psychedelic drug effects 9. Neurobiology of sub-psychedelic doses Section 2 10. Depression and related disorders 11. Addictions 12. Trauma disorders 13. Neurological disorders Section 3 14. Challenges to the developing field of psychedelic medicine political and ethical considerations and commercialization of therapy